| 1 |
Dahlén A, Fletcher CD, Mertens F, et al. Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7; 12)[J]. Am J Pathol, 2004, 164(5): 1645-1653.
|
| 2 |
Kerr DA, Pinto A, Subhawong TK, et al. Pericytoma with t (7; 12) and ACTB-GLI1 fusion: reevaluation of an unusual entity and its relationship to the spectrum of GL-I1 fusion-related neoplasms[J]. Am J Surg Pathol, 2019, 43(12): 1682-1692.
|
| 3 |
Castro E, Cortes-Santiago N, Ferguson LM, et al. Translocation t (7;12) as the sole chromosomal abnormality resulting in ACTB-GLI1 fusion in pediatric gastric pericytoma[J]. Hum Pathol, 2016, 53: 137-141.
|
| 4 |
Koh NWC, Seow WY, Lee YT, et al. Pericytoma with t(7;12): the first ovarian case reported and a review of the literature[J]. Int J Gynecol Pathol, 2019, 38(5): 479-484.
|
| 5 |
Bridge JA, Sanders K, Huang D, et al. Pericytoma with t(7;12) and ACTB-GLI1 fusion arising in bone[J]. Hum Pathol, 2012, 43(9): 1524-1529.
|
| 6 |
Antonescu CR, Agaram NP, Sung YS, et al. A distinct malignant epithelioid neoplasm with GLI1 gene rearrangements, frequent S100 protein expression, and metastatic potential: expanding the spectrum of pathologic entities with ACTB/MALAT1/PTCH1-GLI1 fusions[J]. Am J Surg Pathol, 2018, 42(4): 553-560.
|
| 7 |
Agaram NP, Zhang L, Sung YS, et al. GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions[J]. Mod Pathol, 2019, 32(11): 1617-1626.
|
| 8 |
Liu J, Mao R, Lao IW, et al. GLI1-altered mesenchymal tumor: a clinicopathological and molecular analysis of ten additional cases of an emerging entity[J]. Virchows Arch, 2022, 480(5): 1087-1099.
|
| 9 |
Xu B, Chang K, Folpe AL, et al. Head and neck mesenchymal neoplasms with GLI1 gene alterations: a pathologic entity with distinct histologic features and potential for distant metastasis[J]. Am J Surg Pathol, 2020, 44(6): 729-737.
|
| 10 |
Jo VY, Demicco EG. Update from the 5th edition of the World Health Organization classification of head and neck tumors: soft tissue tumors[J]. Head Neck Pathol, 2022, 16(1): 87-100.
|
| 11 |
Papke DJ Jr, Dickson BC, Oliveira AM, et al. Distinctive nested glomoid neoplasm: clinicopathologic analysis of 20 cases of a mesenchymal neoplasm with frequent GLI1 alterations and indolent behavior[J]. Am J Surg Pathol, 2023, 47(1): 12-24.
|
| 12 |
Rezaee N, Cohen B, Eno C, et al. Primary cutaneous epithelioid mesenchymal tumor with a novel ATP2B4::GL-I1 gene fusion[J]. Am J Dermatopathol, 2023, 45(9): 642-645.
|
| 13 |
Godse NR, Alsulaimani S, Singh AD, et al. Unique case of a GLI1 amplified biphasic mesenchymal tumor of the orbit[J]. Orbit, 2023: 1-5.
|
| 14 |
Machado I, Hosler GA, Traves V, et al. Superficial GLI1-amplified mesenchymal neoplasms: expanding the spectrum of an emerging entity which reaches the realm of dermatopathology[J]. J Cutan Pathol, 2023, 50(6): 487-499.
|
| 15 |
Zeng Y, Yao H, Jiang X, et al. GLI1-altered mesenchymal tumor involving the duodenum: case report and literature review[J]. Int J Surg Pathol, 2023, 31(8): 1538-1547.
|
| 16 |
Punjabi LS, Goh CHR, Sittampalam K. Expanding the spectrum of GLI1-altered mesenchymal tumors—A high-grade uterine sarcoma harboring a novel PAMR1::GLI1 fusion and literature review of GLI1-altered mesenchymal neoplasms of the gynecologic tract[J]. Genes Chromosomes Cancer, 2023, 62(2): 107-114.
|
| 17 |
Palsgrove DN, Rooper LM, Stevens TM, et al. GLI1-altered soft tissue tumors of the head and neck: frequent oropharyngeal involvement, p16 immunoreactivity, and detectable alterations by DDIT3 break apart FISH[J]. Head Neck Pathol, 2022, 16(4): 1146-1156.
|
| 18 |
Hui L, Bai Q, Yang W, et al. GLI1-rearranged mesenchymal tumor in the ovary[J]. Histopathology, 2022, 81(5): 688-692.
|
| 19 |
Shahabi A, Israel AK, Sullivan CB, et al. Fine needle aspiration biopsy of epithelioid-mesenchymal neoplasm with PTCH1-GLI1 fusion: a case report[J]. Diagn Cytopathol, 2022, 50(8): E223-E229.
|
| 20 |
Zhong H, Xu C, Chen X, et al. GLI1-altered epithelioid soft tissue tumor: a newly described entity with a predilection for the tongue[J]. Oral Surg Oral Med Oral Pa-thol Oral Radiol, 2022, 134(1): e14-e22.
|
| 21 |
Liu Y, Huang J, Sun J, et al. GLI1 amplified/fused me-senchymal tumor: a case report and review of the literature[J]. Oral Oncol, 2022, 129: 105897.
|
| 22 |
Argani P, Boyraz B, Oliva E, et al. GLI1 gene alterations in neoplasms of the genitourinary and gynecologic tract[J]. Am J Surg Pathol, 2022, 46(5): 677-687.
|
| 23 |
Ambrosio M, Virgilio A, Raffone A, et al. Malignant epithelioid neoplasm of the ileum with ACTB-GLI1 fusion mimicking an adnexal mass[J]. BMC Womens Health, 2022, 22(1): 104.
|
| 24 |
Rollins BT, Cassarino DS, Lindberg M. Primary cutaneous epithelioid mesenchymal neoplasm with ACTB-GL-I1 fusion: a case report[J]. J Cutan Pathol, 2022, 49(3): 284-287.
|
| 25 |
Klubíčková N, Kinkor Z, Michal M, et al. Epithelioid soft tissue neoplasm of the soft palate with a PTCH1-GLI1 fusion: a case report and review of the literature[J]. Head Neck Pathol, 2022, 16(2): 621-630.
|
| 26 |
Lopez-Nunez O, Surrey LF, Alaggio R, et al. Novel APOD-GLI1 rearrangement in a sarcoma of unknown lineage[J]. Histopathology, 2021, 78(2): 338-340.
|
), 黄幼生2,3(
